WHO releases new target product profiles for urgently needed antibiotics: Geneva Thursday, March 12, 2026, 09:00 Hrs [IST] The World Health Organization (WHO) published three new ...
A newly developed antibiotic called EVG7 could offer a powerful new way to stop Clostridioides difficile, a dangerous gut bacterium that often returns after treatment. In mouse studies, researchers ...
Scientists have created a genomic blueprint for Aeromonas bacteria, which can cause antibiotic-resistant diarrheal disease—with symptoms often misidentified as cholera—in humans and animals.
Antibiotics are designed to wipe out infection-causing bacteria, but even a single course can leave a lasting mark on the gut microbiome, according to a new study of nearly 15,000 adults in Sweden.
Drugmakers must focus on developing new antibiotics to fight hospital “superbugs” including meningitis and other infections that can resist last-line treatments, the World Health Organization (WHO) ...
EL MUNDO on MSN
The use of certain antibiotics leaves a mark on the intestinal microbiota that lasts between four and eight years after taking them
A study of nearly 15,000 adults finds a lasting association between the use of certain antibiotics and the balance of the intestinal microbiota. The intestinal microbiota, the community of bacteria ...
We need a reliable pipeline with new antibacterial agents that are innovative, affordable, accessible to all those who need ...
Lead clinical candidate CTX-187 is a novel antimicrobial immunotherapy developed to treat clinically-prevalent and multi-drug resistant Gram-negative bacterial infections Qualified Infectious Disease ...
Lead clinical candidate CTX-187 is a novel antimicrobial immunotherapy developed to treat clinically-prevalent and multi-drug resistant Gram-negative bacterial infections -- Qualified Infectious ...
Daily Democrat on MSN
Precision is key to reducing antibiotic use on dairies
When cows develop mastitis, dairies often respond with immediate antibiotic treatment. That approach has long protected ...
GARDP has acquired all data and licensing rights for apramycin, an aminoglycoside antibiotic used in veterinary medicine, and will evaluate its potential to treat highly drug-resistant infections in ...
Researchers report that photodynamic therapy increases antibiotic penetration and disrupts resistance mechanisms in laboratory strains.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results